'Don’t accept small health basket budget'

Former head of public c'tee Prof. Menachem Fainaru calls on the new committee to refuse to convene next week.

By
October 27, 2011 04:03
2 minute read.
RAFAEL BEYAR

RAFAEL BEYAR. (photo credit: (Courtesy/Rambam Health Care)

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

The former head of the public committee to recommend how to expand the basket of medical technologies called on the new committee to refuse to convene next week.

The budget agreed upon by the Treasury and Health Ministry for 2012 was too small to meet the needs of patients, he said.

Be the first to know - Join our Facebook page.


Prof. Menachem Fainaru, former dean of Tel Aviv University’s Sackler Faculty of Medicine, who was chairman of the “basket committee” in 2008 and 2009, said Wednesday that the NIS 300 million allocated will provide new medications and other medical technologies to only a quarter of the patients who need them. In his day, said Fainaru, he had NIS 450 million to add to the basket, and even then, the decisions were very difficult to make.

Speaking at a meeting of the Coalition of Organizations for the Right to Health, Fainaru and others called on the new committee headed by Rambam Medical Center Director-General Prof. Rafael Beyar to “take responsibility, not give in and not to start with such a small budget.”

The coalition insists on an automatic two percent increase in the basket of services, which has been demanded by health experts for years but has been rejected by the Finance Ministry, which has veto power on health allocations.

Shmuel Ben-Ya’acov, a member of the coalition, said Treasury allocations to reach agreements with the hospital residents and the new labor agreement with the Israel Medical Association will “erode the budget for the health basket,” causing the situation to worsen. The proposed medications save, prolong or improve the quality of life, and failure to add them harms the public. Never before has the public had to pay so much out of pocket on health expenses as the Treasury reduces its share, he said.

Former MK Haim Oron, who is also part of the coalition, said the social gaps in health care are “huge and terrible.”

JPOST VIDEOS THAT MIGHT INTEREST YOU:


In 2008, the public committee had NIS 500 million to allocate new technologies, but today there is only NIS 300 million to choose among 600 ones that have been presented for consideration.

Only 8% of the Gross Domestic Product is spent healthcare, and the public pay 40% of that, the coalition members said.

The government has not yet committed itself to allocate any money to expand the basket in 2013. Polls have shown that 14% of adults forgo medication and treatments and medication because they can’t afford even the copayments for the subsidized drugs they need.

The speakers said that in recent years, the Health Ministry – which has no power to set the sum for expansion of the basket – has claimed that NIS 300 million is “enough” for a year. “But,” said its critics, “this includes only lifesaving drugs and not those who prolong life or improve the quality of life for patients.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

Lab
August 31, 2014
Weizmann scientists bring nature back to artificially selected lab mice

By JUDY SIEGEL-ITZKOVICH